Seeking Alpha

CYTR
CytRx Corporation - NASDAQ

4/21/2014, 12:25 AM ET
Quote & Analysis Breaking News StockTalk
cytr chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
PRO Articles
There are 2 articles on this stock available only to PRO subscribers.
Other Articles
There are no Transcripts on CYTR.
CYTR vs. ETF Alternatives
Company Description

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes three clinical-stage drug candidates in various stages of development: Aldoxorubicin, Tamibarotene, and Bafetinib.

Sector: Healthcare
Industry: Biotechnology
Country: United States